Publications by authors named "Nina D Russell"

Claim this Profile
I
Iterative hypothesis testing in HIV vaccine research: moving towards success.
Pervin Anklesaria, Nina D Russell

J Int AIDS Soc· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of partnerships in accelerating HIV vaccine research and development.
Mark B Feinberg, Nina D Russell, Robin J Shattock, Karie B Youngdahl

J Int AIDS Soc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pox-Protein Public Private Partnership program and upcoming HIV vaccine efficacy trials.
Nina D Russell, Mary A Marovich

Curr Opin HIV AIDS· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.
Sharon E Frey, Laurence Peiperl, M Juliana McElrath, Spyros Kalams, Paul A Goepfert, Nina D Russell

Clin Vaccine Immunol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel directions in HIV-1 vaccines revealed from clinical trials.
Jean-Louis Excler, Georgia D Tomaras, Nina D Russell

Curr Opin HIV AIDS· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines.
Wayne C Koff, Nina D Russell, Mark Walport, Mark B Feinberg, John W Shiver

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.
Geoffrey J Gorse, Lindsey R Baden, Margaret Wecker, Mark J Newman, Guido Ferrari, Nina D Russell

Vaccine· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
Nina D Russell, Barney S Graham, Michael C Keefer, M Juliana McElrath, Steve G Self

J Acquir Immune Defic Syndr· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical evaluation of HIV vaccines in early clinical trials.
Zoe Moodie, A J Rossini, Michael G Hudgens, Peter B Gilbert, Steven G Self, Nina D Russell

Contemp Clin Trials· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials.
Michael G Hudgens, Steven G Self, Ya-Lin Chiu, Nina D Russell, Helen Horton

J Immunol Methods· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.
Nina D Russell, Michael G Hudgens, Richard Ha, Colin Havenar-Daughton, M Juliana McElrath

J Infect Dis· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis